Nektar Therapeutics
NKTR
$1.43
Share price
8.40%
Change (1 day)
90.67%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.26 B
According to Nektar Therapeutics 's latest financial reports the company's total liabilities are $0.26 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | -22.36% |
| 2022-12-31 | $0.34 B | -21.41% |
| 2021-12-31 | $0.43 B | -5.16% |
| 2020-12-31 | $0.46 B | -19.32% |
| 2019-12-31 | $0.57 B | 32.22% |
| 2018-12-31 | $0.43 B | 2.75% |
| 2017-12-31 | $0.42 B | -12.42% |
| 2016-12-31 | $0.48 B | -2.33% |
| 2015-12-31 | $0.49 B | 21.45% |
| 2014-12-31 | $0.40 B | -22.72% |
| 2013-12-31 | $0.52 B | 16.34% |
| 2012-12-31 | $0.45 B | 10.28% |
| 2011-12-31 | $0.40 B | -5.07% |
| 2010-12-31 | $0.43 B | -9% |
| 2009-12-31 | $0.47 B | 27.75% |
| 2008-12-31 | $0.37 B | -27.47% |
| 2007-12-31 | $0.51 B | -5.63% |
| 2006-12-31 | $0.54 B | 1.76% |
| 2005-12-31 | $0.53 B | 91.56% |
| 2004-12-31 | $0.27 B | -38.67% |
| 2003-12-31 | $0.45 B | 13.19% |
| 2002-12-31 | $0.39 B | 0.74% |
| 2001-12-31 | $0.39 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 36,891.38% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 51,281.78% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 33,947.32% | 🇺🇸 USA |
 Baxter BAX | $19.80 B | 7,317.45% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 25,753.22% | 🇺🇸 USA |
 AstraZeneca AZN | $64.79 B | 24,162.49% | 🇬🇧 UK |
 Richardson Electronics RELL | $34.98 M | -86.90% | 🇺🇸 USA |
 Alkermes ALKS | $0.93 B | 249.58% | 🇮🇪 Ireland |